GV
Venture firm launched as Google Ventures in 2009 and headquartered in the San Francisco Bay Area. It invests from seed to growth stages across technology and life sciences.
- Type
- Venture capital firm
- Location
- San Francisco Bay Area
- Website
- https://www.gv.com
- Investment focus
- technology, life sciences
- Stages
- seed, growth
About
GV says it was launched as Google Ventures in 2009 and took the name GV in 2015. It invests from seed to growth stages across the technology and life sciences sectors, with portfolio companies across North America, Europe and Israel. Its About page lists its headquarters as the San Francisco Bay Area, with offices in New York, Cambridge and London. The Armadin sources call it Google Ventures.
GV participated in Estuary Biotherapeutics' $93 million Series A, announced on 2026-10-16. RA Capital Management led. The company release says GV and 4BIO Capital co-led a $10 million seed. That seed is not a separate round page.
TechCrunch names GV as a participant in Flapping Airplanes' $1 billion Series A, announced on 2026-10-21. The company site says Google Ventures. The issue says Alphabet's GV. Index Ventures and Lux Capital led. None of those sources calls GV the lead of the Series A. TechCrunch also describes a $180 million seed that included GV. That seed is not a page here.
Funding rounds on RaiseTrack
| Company | Round | Date | Role |
|---|---|---|---|
| Flapping Airplanes | Series A 2026 | 2026-10-21 | participant |
| Estuary Biotherapeutics | Series A 2026 | 2026-10-16 | participant |
| Arboretum LifeSciences | Series A 2026 | 2026-10-06 | lead |
| Armadin | Series B 2026 | 2026-10-01 | participant |
Sources
Last verified:
- https://www.gv.com/about/
Type: official investor website. Accessed 2026-10-08.
GV About page, read in a browser because the site blocks plain requests. Source of the 2009 launch as Google Ventures, the 2015 rename, the seed to growth focus in technology and life sciences, and the headquarters and offices. - https://estuarybio.com/news/estuary-series-a
Type: company announcement. Accessed 2026-10-19.
Estuary Biotherapeutics release, 16 October 2026. Says GV co-led the company's $10 million seed with 4BIO Capital and participated in the $93 million Series A led by RA Capital Management. - https://www.4biocapital.com/single-post/estuary-biotherapeutics-launches-with-103-million-to-advance-targeted-gene-therapies-for-kidney-dis
Type: official investor website. Accessed 2026-10-19.
4BIO Capital post, 16 October 2026. Says GV co-led the $10 million seed and participated in the Series A. - https://buttondown.com/raisetrack/archive/raise-track-update-2026-10-19/
Type: other verified public source. Accessed 2026-10-19.
Raise Track Update for 2026-10-19. Names GV as a participant in Estuary Biotherapeutics' $93 million Series A. - https://techcrunch.com/2026/10/21/year-old-ai-lab-flapping-airplanes-raises-1b-at-a-6b-valuation/
Type: reputable publication. Accessed 2026-10-27.
TechCrunch, October 21, 2026. Names GV as a participant in Flapping Airplanes' $1 billion Series A. Does not call GV a lead. Also describes a $180 million seed that included GV. That seed is not a page here. - https://flappingairplanes.com/
Type: official company website. Accessed 2026-10-27.
Flapping Airplanes home page, read 2026-10-27. Says Google Ventures and lists it among the backers of a $1 billion Series A. The issue says Alphabet's GV. Both names point at this page. - https://buttondown.com/raisetrack/archive/raise-track-update-2026-10-26/
Type: other verified public source. Accessed 2026-10-27.
Raise Track Update for 2026-10-26. Names Alphabet's GV as a participant in Flapping Airplanes' Series A, led by Index Ventures and Lux Capital.